ENTER
  • 17th Meet the Professor. Advanced International Breast Cancer Course

    Mortality from breast cancer is declining in most countries thanks to effective screening programs, early diagnosis, molecular characterization of the different subtypes and biology-driven treatments. A multidisciplinary management of breast cancer patients is therefore the key to success and a breast multidisciplinary team should include - besides the “classic” clinical specialties - pathologists, molecular biologists and geneticists. Furthermore, the availability of multiple diagnostic and therapeutic choices, the increasing costs of new technologies and drugs and the issue of sustainability represent a new challenge for socially-responsible clinicians. With this goal in mind, the Programme includes lectures on molecular characterization, updated treatments of early and advanced disease, management of difficult cases and hereditary syndromes and issues of sustainability and drug access across countries.

  • Programma dell’attività formativa

    Introduction - Pierfranco Conte, Gabriel N. Hortobagyi, Valentina Guarneri, Philip Poortmans

    Obesity and Cancer - Roberto Vettor

    Management of women BRCA 1/2 and other predisposition gene mutations - Shani Paluch-Shimon

    Axillary dissection: still an option? - Elefterios Mamounas

    Hot topics in breast cancer RT - Philip Poortmans

    Clinical impact of genomics in BC - Aleix Prat

    PIK3CA testing: from technical aspects to clinical application - Sybille Loibl

    Prognostic signatures to guide treatment decision - Gabriel N. Hortobagyi

    Adjuvant CDK4/6i for HR+ disease: reconciling data from randomized trials - Valentina Guarneri

    Early BRCAm (BreastCancer mutation) tumors: PARPi are coming! - Pierfranco Conte

    Neoadjuvant therapy for early breast cancer: beyond the pCR dogma - Pierfranco Conte

    Immunotherapy for early TNBC: hopes and hypes - Hope Rugo

    Antibody Drug Conjugates for BC - Frederik Marmè

    Targeting unconventional pathways in Luminal BC - Maria Vittoria Dieci

    Treatment algorithm for HR+/HER2- ABC - Stephen Johnston

    Treatment algorithm for HER2+ ABC - Sandra Swain

    Treatment algorithm and new options for TN ABC - Miguel Martin

  • Obiettivo formativo nazionale

    Contenuti tecnico-professionali (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica, ivi incluse le malattie rare e la medicina di genere

  • Verifica Apprendimento Partecipanti

    Questionario a risposta multipla e a doppia randomizzazione. Si effettua online con l'obbligo di rispondere correttamente ad almeno il 75 percento delle domande per il suo superamento. È prevista la possibilità di ripetizione in caso di esito negativo